Indian podiatric startup forays into prescription footwear manufacturing

FootSecure, a healthcare startup specialising in podiatric medicine and wound care, has recently launched its state-of-the-art custom footwear manufacturing unit in Bengaluru, India, with the support of the Karnataka Institute of Endocrinology & Research.

Set up with an initial investment of Rs 30 lakh, FootSecure’s prescription footwear manufacturing facility offers carefully designed footwear based on the pathology and biomechanics of the foot, ensuring stability, injury prevention, and comfort.

Currently, FootSecure offers six models, with four options for women and two for men, starting from Rs 2000 onwards. The advanced customisations offered are also comprehensive and include the outer sole, midsole, insole, and uppers, most of which are particularly beneficial for patients with aches and pain in the foot, diabetes, arthritis, congenital foot disorders, post-accident foot deformities, and post-surgical foot anomalies. The manufacturing facility has the capacity to produce up to 300 pairs of custom offloading footwear per day. 

Besides the custom footwear app, FootSecure also has a proprietary digital ecosystem, Wound360, and Foot360, that empowers healthcare providers with guidelines and a vast knowledge base for diagnosis, treatment, support, and rehabilitation. 

FootSecure plans to expand into new geographies and introduce innovative solutions, services, and products. By 2025, the company aims to establish India’s first dedicated podiatry hospital and launch a brand of specialised therapeutic footwear designed by medical experts from India and Australia.